Details werden geladen...
FDA warns weight loss drugs may increase risk of sudden vision loss | CNN
The FDA is requiring new safety warnings for popular GLP-1 weight-loss medications over a potential increased risk of a rare eye condition that can cause sudden vision loss.
Ähnliche Seiten
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss - Ars Technica
https://arstechnica.com/health/2026/11/glp-1-drugs-may-increase-risk-of-vision-loss-from-rare-condition-fda-warns/
FDA Warning: Rare risk linked to weight-loss drugs | Israel National News
https://www.israelnationalnews.com/flashes/697131
Ozempic and Wegovy linked to rare risk of sudden vision loss | ScienceDaily
https://www.sciencedaily.com/releases/2026/10/261014015521.htm
FDA Adds Vision Loss Warning To Popular GLP-1 Drugs | HuffPost Latest News
https://www.huffpost.com/entry/fda-adds-rare-vision-loss-warning-to-popular-glp-1-drugs_n_6af27d2ae4b08067d84b6679
FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness
https://www.nbcnews.com/health/health-care/fda-orders-new-warning-glp-1s-rare-eye-condition-linked-sudden-blindne-rcna608309